Stock Quote
Perrigo Co (PRGO.O) (Nasdaq)
sector: Healthcare .
industry: Pharmaceuticals - Generic & Specialty ยท
View PRGO on other exchanges
$39.75
4:00pm EST
+1.12%
$39.31
$39.68
388,952
$39.97
$39.48
$40.55
$18.54
0.78
652,024
PRGO.O
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Papa, Joseph | Chairman of the Board, President, Chief Executive Officer | 3,674,023 |
| Brown, Judy | Chief Financial Officer, Executive Vice President | 1,168,219 |
| Kingma, Todd | Executive Vice President, General Counsel, Secretary | 1,222,256 |
Profile
Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients, and pharmaceutical and medical diagnostic products. The Company operates in three segments: Consumer... Full Description
Company Address
Perrigo Co
515 Eastern Avenue
Allegan MI 49010
P: +1269.6738451
F: +1269.6737534
515 Eastern Avenue
Allegan MI 49010
P: +1269.6738451
F: +1269.6737534
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| NBTY, Inc. | $42.21 | +0.36 |
| Taro Pharmaceutical Industries Ltd. | $9.25 | 0.00 |
| Teva Pharmaceutical Industries Limited | ₪20,160.00 | 0.00 |
| PRGO.O | Industry | |
|---|---|---|
| P/E(TTM) | 2.34 | 3.57 |
| P/S(TTM) | 1.73 | 0.57 |
| ROI(TTM) | 77.73 | 1.86 |
| ROE(TTM) | 169.46 | 2.51 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | 0.57 |
| EPS Est. (Current Year) | 1.83 |
| Total Revenue | $528.00M |
| Net Income | $61.03M |
| EPS | $0.65 |
